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Abstract
Neutrophil swarms protect healthy tissues by sealing off sites of infection. In the absence of 
swarming, microbial invasion of surrounding tissues can result in severe infections. Recent 
observations in animal models have shown that swarming requires rapid neutrophil responses and 
well-choreographed neutrophil migration patterns. However, in animal models physical access to 
the molecular signals coordinating neutrophil activities during swarming is limited. Here, we 
report the development and validation of large microscale arrays of zymosan-particle clusters for 
the study of human neutrophils during swarming ex vivo. We characterized the synchronized 
swarming of human neutrophils under the guidance of neutrophil-released chemokines, and 
measured the mediators released at different phases of human-neutrophil swarming against targets 
Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, 
subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms
Correspondence and requests for materials to Daniel Irimia, dirimia@mgh.harvard.edu. 
Code availability
The computer code for chemotaxis analysis and diffusion modeling is available in Github at https://github.com/hunterelliott/
ChemotaxisModelling
Data availability
The authors declare that all data supporting the findings of this study are available within the paper and its supplementary information. 
Source data for the figures in this study are available in figshare with the identifier doi:10.6084/m9.figshare.5024567 (ref. 45).
Author contributions
E. R. and D. I. designed research. E. R., A. H. K., F. J., H. C. and E. W. designed and prepared microfluidic devices. E. R. conducted 
experiments. E. R., F. J., H. E., J. L. and D. I. analyzed results. C. N. S. and J. D. performed metabololipidomic analysis. H. E. 
developed the biophysical model for cell swarming. E. R. and D. I. prepared the manuscript, with significant contributions from all 
authors.
Competing financial interests
The authors declare no competing financial interests.
HHS Public Access
Author manuscript
Nat Biomed Eng. Author manuscript; available in PMC 2017 December 30.
Published in final edited form as:
Nat Biomed Eng. 2017 ; 1: . doi:10.1038/s41551-017-0094.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
simulating infections. We found that the network of mediators coordinating human-neutrophil 
swarming includes start and stop signals, proteolytic enzymes and enzyme inhibitors, as well as 
modulators of activation of other immune and non-immune cells. We also show that the swarming 
behavior of neutrophils from patients following major trauma is deficient and gives rise to smaller 
swarms than those of neutrophils from healthy individuals.
Neutrophils represent the largest population of white blood cells in circulation. They are the 
first to accumulate in tissues after injury, infections, or inflammation. They are capable of 
swarming, a process by which they insulate areas of infection and injury from surrounding 
viable tissues, thus playing key roles in protecting the body from microbial infections and 
inflammation. Growing evidence of neutrophils swarming around microbes and damaged 
cells challenges the current paradigm regarding neutrophil accumulation under the exclusive 
control of chemoattractants released by microbes and tissue damage 1,2. A new paradigm is 
emerging where neutrophils are active players, participating in their own recruitment 3. 
Studies in mice have recently identified leukotriene B4 (LTB4) as the “unique intercellular 
communication signal between neutrophils” for the recruitment of cells during swarming 2. 
At the same time, a role for other chemokines and receptors during the aggregation phase of 
swarming has been proposed, supported by evidence from knockouts for single receptor 
genes 2,4. However, the poor control over the conditions in tissues and the challenges of 
measuring inter-cellular molecular signals are significant barriers for dissecting the 
complexity of the neutrophil interactions during the different phases of swarming in vivo 1,2. 
In addition, it is not clear whether the mechanisms identified in mice 1,2 could be directly 
extrapolated to human neutrophils, because of known differences in migration and 
chemokine responses between human and mouse neutrophils 5. Even though neutrophil 
swarming has been observed in vitro around dying cells 6, no experimental system today can 
perform the precise and high-throughput characterization of human neutrophil swarming 
necessary to accelerate our understanding of the swarming processes and its mediators.
The well-choreographed recruitment of neutrophils by swarming is a key determinant for 
limiting the extent of infections with various pathogens7. Examples, supported by in vivo 
observations in animal models, include the neutrophil response to Staphylococcus aureus 8,9, 
Escherichia coli 10, Listeria monocytogenes 10, or Toxoplasma gondii 11. Moreover, 
swarming contributes to effective responses to filamentous fungi like Aspergillus 12,13. 
Unlike the typical chemotaxis of cells towards sources of diffusing attractant molecules, 
neutrophil swarming is characterized by an early, progressively accelerated, exponential 
accumulation of neutrophils at sites of infection or injury. The process is tightly controlled 
and stops promptly once the infection and/or injury site has been insulated from the 
surrounding healthy tissue 4,7. Deficiencies of attracting large numbers of neutrophils around 
Aspergillus conidia may be responsible for the progression of infections in patients during 
immunosuppressive therapy 13, and decreased ability to neutralize Staphylococcus following 
major trauma 14. Swarming also reaches clinical relevance when neutrophil response and 
accumulation is excessive and leads to tissue destruction e.g. transient swarms during 
inflammation in the lungs 10 and inflammation flares around uric acid crystals during gout 
disease 15. Therefore, interventions to modulate neutrophil swarming, by reducing it in 
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conditions of detrimental inflammation or enhancing it during certain infections, could 
amend the disease processes and potentially improve conditions in patients.
Here, we designed a microscale array of particle-clusters to control and monitor the 
swarming behavior of human neutrophils and performed a comprehensive study of the 
signals mediating interactions between human neutrophils during swarming. This microscale 
array of particle-clusters enables the detailed study of hundreds of neutrophil swarms, 
synchronized in time around large arrays of identical targets. We found that both the size and 
the spacing of particle-clusters are critical for triggering swarming neutrophil behavior. We 
also identified a constellation of 45 mediators released by human neutrophil during 
swarming and absent in controlled conditions. A complex picture is emerging for the 
communication between human neutrophils during swarming, comprising both lipid and 
protein that act as start and stop signals for neutrophils, as well as mediators for the activities 
of monocytes, lymphocytes, and several non-inflammatory cells. Several mediators are 
apparently redundant and their contribution to swarming becomes important only when 
dominant ones are inhibited. Moreover, we tested the swarming ability of neutrophils in 
patients after trauma and found significant deficits that ameliorate during the hospital stay. A 
better understanding of the mediators of neutrophils swarming will ultimately enhance our 
abilities to control infections and chronic inflammation in patients.
Results
Requirements for neutrophil swarming on microscale array of particle clusters
We manufactured large-scale arrays of clusters of zymosan particles by first micropatterning 
a cationic copolymer polyelectrolyte of acrylamide (ZETAG® 8185) and then trapping 
precisely controlled numbers of negatively charged, micron-sized zymosan particles on top 
of these micropatterns (Fig. 1a, Supplementary Fig. 1). We produced targets of controlled 
size, dimensions, composition, and spacing, employed the arrays of zymosan-particle 
clusters as targets for human neutrophil accumulation. We observed that neutrophils 
converge towards particle clusters within minutes after loading the neutrophil suspension 
(Fig. 1b, c). In the presence of serum free media, the first neutrophils arrive to the targets by 
chance during the loading of the devices and subsequent neutrophils are guided by mediators 
released from the first cells. Human neutrophils formed swarms only around particle clusters 
larger than 17.5 µm2 in size (more than 3 zymosan particles in a cluster) and spaced further 
than 20 µm distance from each other (Fig. 1d, Supplementary Fig. 2, Supplementary Video 
1–3). Smaller clusters (1–2 zymosan particles), which were phagocytosed by individual 
neutrophils, did not induce swarming. Neutrophils colocalized above the smaller particle 
clusters and were employed as controls for the swarming experiments. Neutrophils placed 
on patterns in the absence of particles remained spherical and lacked evidence of activation 
(non-activated controls).
Swarming starts after neutrophils moving randomly on the surface of the microscale array 
encounter zymosan-particle clusters (scouting phase – represented as relative time 0 min, 
Fig. 1e). Within minutes after the initial interactions with particle clusters, increasing 
numbers of neutrophils start migrating towards the first neutrophils (growth phase). Swarms 
reach their maximum size at 40–70 minutes later, after which they stop growing (plateau 
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phase – Supplementary Table 1). During the plateau phase, neutrophils migrate in and out of 
the swarms, reflecting the dynamic nature of swarms at equilibrium. The assay is 
quantitative (Supplementary Fig. 3) and has high reproducibility, which we validated by 
comparing the swarming of neutrophils from the same donor in three separate assays (59.3 
± 8 µm2 particle cluster size, 100 µm spacing, Fig. 1e). The differences between the 
dynamics of swarms in repeated experiments from the same donor are smaller than the 
differences between healthy donors (Fig. 1f).
Neutrophils can leave smaller swarms to join adjacent larger swarms. When zymosan-
particle clusters of different size are spaced close together (distances between 40 and 60 
µm), swarms around smaller clusters grow to a size that is on average one-third of the size of 
those around larger particle clusters (Fig. 1g, h). While the initial neutrophil recruitment 
occurs at the same rate on adjacent swarms, with time, swarms around smaller particle 
clusters reach the plateau phase and stop growing while swarms around larger clusters 
continue to grow. On average, two-dozen neutrophils leave each of the smaller swarms to 
join the adjacent larger swarms, increasing their size (Supplementary Fig. 4). When 
zymosan particle clusters of different size are positioned in arrays with spacing greater than 
80 µm, they induce swarms of comparable size, even when particle clusters are up to twice 
the size of adjacent particle clusters. These observations show the presence of long-range 
interactions between adjacent swarms and indicate the presence of gradients of soluble 
mediators released from swarms, which guide the migration of neutrophils.
Several chemoattractants guide human neutrophil swarming
We verified that leukotriene B4 (LTB4), a signaling lipid playing a vital role during 
swarming in mice 2, is also mediating the swarming of human neutrophils. For this, we 
monitored neutrophil swarming in the presence of BLT1 and BLT2 receptor antagonists 
(U75302 and LY255283, Fig. 2a–d and 2e–h). We measured a reduction in the size of 
swarms in the presence of the antagonists (Fig. 2a, e). We measured a significant decrease in 
mean velocity of individual neutrophils migrating towards the swarms during the growth 
phase, from 15 µm/min in control conditions to 7 µm/min for neutrophils exposed to BLT1 
and BLT2 receptor antagonists (Fig. 2b, c, f, g and Supplementary Fig. 5). It was interesting 
to note that the growth phase was significantly slower in the presence of BLT1 and BLT2 
receptor antagonists. Neutrophil recruitment velocity was uniform over time, with no 
noticeable acceleration during the growth phase. The analysis of the trajectories of 
neutrophils joining the swarms also revealed significant changes. The chemotactic index 
(CI) decreased significantly, and migration patterns became disorganized in the presence of 
BLT1 and BLT2 receptor antagonists (CI = 0.5) compared to neutrophils in control 
conditions (CI = 0.94, Fig. 2d, h, Supplementary Fig. 4). Simultaneously, the radius of 
neutrophil recruitment was reduced from 300 ± 30 to 120 ± 30 µm (n = 16, p < 0.05). The 
average ratio between swarm and particle cluster size (δRatio) was reduced from 2 ± 0.3× to 
1.2 ± 0.2× (n = 14, p < 0.05, Fig. 2i, j). These results are in agreement with the in vivo 
measurements that showed that the recruitment of mouse neutrophils lacking LTB4 receptors 
is drastically impaired 2. Similar to the insights from mice, our results also suggest that 
additional chemoattractant signals, besides LTB4, may contribute to the swarming of human 
neutrophils.
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We guided our search for additional chemoattractants by employing a biophysical model to 
leverage the measured changes in the timing of motility initiation, the original location of 
neutrophils joining the swarms, and the characteristics of neutrophil movement in the 
vicinity of swarms (Supplementary Fig. 6). The model provided estimates of 
chemoattractant diffusivity and helped narrow the range of potential chemoattractants for 
neutrophils during swarming. We started by validating the biophysical model on human 
neutrophil swarming in control conditions. The results from the model were consistent with 
a chemoattractant that diffuses rapidly away from swarms (1.2 ± 0.4 × 10−10 m2/s) and the 
characteristic fast, persistent, and highly directional migration of human neutrophils in LTB4 
gradients 16 (Fig. 2k and 2l; experimental and simulation results, respectively. 
Supplementary Video 4). In the presence of BLT1 and BLT2 receptor antagonists, the results 
of the biophysical model were consistent with the activity of a chemoattractant with slower 
diffusivity (0.6 ± 0.4 × 10−10 m2/s) guiding the migration of neutrophils towards swarms. 
Moreover, the convoluted trajectories of neutrophils towards swarms and lower migration 
speed were consistent with the bi-directional signature motility patterns of neutrophils in the 
presence of CXCL8 and C5a chemoattractants 16. Together, the results of the biophysical 
model and chemoattractant signatures support the involvement of additional 
chemoattractants, besides LTB4, during human neutrophil swarming, with LTB4 signaling 
reinforced by higher molecular weight chemoattractants (Fig. 2m and 2n; experimental and 
simulation results, respectively. Supplementary Video 5).
Guided by these experimental and biophysical modeling results, we probed the contribution 
of CXCL8 and heat-labile factors (e.g. complement) during neutrophil swarming (Fig. 3a, 
b). We compared the recruitment of neutrophils in the presence of regular (CI = 0.94 ± 0.04) 
and heat-inactivated serum in the medium. In heat inactivated serum, we observed a 
reduction in the chemotactic index (CI = 0.88 ± 0.04, p < 0.05) (Fig. 3c), a lower number of 
neutrophils in the plateau phase, and a less than 10 min delay before the establishment of a 
stable recruitment phase (Fig. 3d). The combination of BLT1 and BLT2 antagonists and 
heat-inactivated serum further reduced the recruitment of neutrophils to swarms (Fig. 3a, b, 
d). Together, these results indicate that heat-labile factors play a non-redundant role during 
swarming, and become important in the absence of LTB4 mediated guidance. Moreover, we 
measured no decrease of the chemotactic index in the presence of CXCR1 and CXCR2 
blocking antibodies (CI = 0.87 ± 0.04) when compared to experiments in heat-inactivated 
serum. The chemotactic index decreased significantly when the blocking of BLT1 and BLT2 
occurred in the presence of heat-inactivated serum (CI = 0.74 ± 0.04, p < 0.05), and 
decreased even further with the additional blocking of CXCR1 and CXCR2(CI = 0.62 
± 0.04, p < 0.05, Fig. 3c). The number of neutrophils recruited to the swarms was further 
reduced when serum was replaced with human albumin, suggesting that other factors in 
serum contribute to swarming (Fig. 3e). Interestingly, despite being slowed significantly, 
neutrophil recruitment to the swarms was not completely abolished even after interference 
with all recruitment factors identified so far, including the LTB4, CXCL8, and heat-labile 
serum factor(s) (Fig. 3d, e).
Reátegui et al. Page 5
Nat Biomed Eng. Author manuscript; available in PMC 2017 December 30.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Lipid mediators of human neutrophil swarming
To identify additional signals, we probed the presence of other lipid mediators, besides 
LTB4, in the supernatant and released by human neutrophils during swarming. Such 
measurements were enabled by the augmented concentration of mediators in the 
supernatant, favored by the synchronized release and the small volume of fluid above the 
swarms. We focused on the presence of lipid mediators of inflammation and resolution 
derived from arachidonic acid (AA), eicosapentaenoic acid (EPA), or docoshexaenoic acid 
(DHA), previously associated with the temporal dynamics of acute inflammation and 
resolution 17 (Fig. 4a, b, Supplementary Fig. 7). We found that during swarming, in addition 
to LTB4, human neutrophils also produce large amounts of lipoxin A4 (LXA4), resolvin E3 
(RvE3), prostaglandins D2 (PGD2) and E2 (PGE2) (Supplementary Table 2). Interestingly, 
there is almost a 20-fold increase in the production of LXA4 at three hours, while RvE3 
peaks early and remains nearly constant after one hour. The PGD2 and PGE2 prostaglandins 
have a peak in production in the first 30 minutes (2.5 ± 0.9 pg/mL) after the initiation of 
swarming, comparable to maximum LTB4 levels (4.4. ± 1.0 pg/mL), suggesting a complex 
interplay of signals and the presence of an equilibrium point or “eicosanoid switch” 18. 
Using this microscale array of particle-clusters, we also identified neuroprotectin D1/
protectin D1 (NPD1/PD1), which is also a chemical signal and member of the specialized 
pro-resolving mediators superfamily 19. Although it was released from neutrophil swarms, 
we did not observe temporal changes in its levels during the growth of the swarms. We 
verified the role of LXA4 as a stop signal during neutrophil swarming by pre-treating the 
neutrophils with LXA4 before the swarming assay and by adding LXA4 to the media during 
swarming. We observed significantly smaller swarms, that grow at significantly slower rates 
in the presence of LXA4 compared to controls (Fig. 4c).
Protein mediators of human neutrophil swarming
We also investigated the release of protein mediators in the small volume above the array of 
synchronized neutrophil swarms. We employed multiplex quantitative ELISA and measured 
the concentrations of 440 cytokines, proteases, protease inhibitors, and soluble receptors in 
the supernatant, at 30, 60 and 180 minutes after the start of swarming (Supplementary Table 
3). We identified ten proteins released at significantly higher levels by human neutrophils 
during swarming (Fig. 5a, Supplementary Tables 4 and 5). Among these, Galectin-3 is 
secreted at ∼10 fold higher levels by swarming than non-swarming neutrophils, and ∼100 
fold higher than those released by non-activated controls. Additional support for the 
contribution of the ten swarm-specific molecular species to swarming dynamics is provided 
by the increase in their concentrations at 30, 60 and 180 minutes after the initiation of 
swarming (Fig. 5c). We also found 29 released proteins at distinct levels between activated 
neutrophils (swarming and non-swarming) and controls (Fig. 5b, Supplementary Tables 5 
and 6). Several other proteins contribute to the activation and migration of other immune and 
non-immune cells. The levels of these proteins change over time, for example, we measured 
a 30 fold increase in peptidoglycan recognition proteins (PGRP-S) during swarming 
(Supplementary Fig. 8).
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Altered swarming behavior of neutrophils from patients
We probed the swarming behavior of neutrophils from patients after trauma and found that 
they are recruited slower and give rise to smaller swarms compared to the neutrophils from 
healthy individuals. We isolated neutrophils from 16 blood samples collected from 8 trauma 
patients at 2–3 days interval (Supplementary Table 7). We found that the ability of 
neutrophils to form swarms is significantly reduced and the size of swarms for neutrophils 
from patients is smaller than neutrophils from healthy controls (Fig. 6a). In patients, the 
plateau swarm size was 645.8 ± 144.1 µm2, 698.3 ± 212.8 µm2, and 635.2 ± 191.9 µm2 for 
trauma, autoimmune disease, and sepsis patients respectively. However, experimental 
controls run at the same conditions had a plateau size at 1373.2 ± 378.8 µm2 (Fig. 6b). For 
patients recovering after trauma, the average size of the swarms was smaller in the early 
days after trauma and increased at later time points (Fig. 6c). Detailed observations of 
neutrophil dynamics during swarming showed a significant delay in the initiation of 
swarming after interaction with zymosan particle clusters (scouting phase) and slower 
growth - Fig. 6d). We also measured larger variations in the migration speed towards swarms 
for neutrophils from patients compared to controls (Supplementary Fig. 9).
Discussion
We employed arrays of thousands of clusters of zymosan particles to perform comprehensive 
studies of human neutrophil swarming. This microscale array enables comprehensive studies 
of human neutrophils and overcomes significant limitations of previous studies. For 
example, the study of neutrophil swarming in mouse and zebrafish models 1,2,16 lacks 
control over the target size and triggers the response of heterogeneous populations of 
leukocytes from which the molecular signals released by neutrophils cannot be dissected. A 
key feature of the microscale array is the ability to synchronize the swarming of thousands 
of neutrophils. In combination with the low volume of supernatant, this enables 
unprecedented sensitivity for measuring signaling molecules released at different stages 
during swarming. Moreover, the microscale array enables comparisons between neutrophils 
interacting with particles in swarming and non-swarming conditions, which share the 
activation by the same zymosan particles and are distinct from un-activated neutrophils. The 
precise control of the size of the zymosan-particle clusters is key for these controls and 
leverages the dependence of swarming on the size of the clusters and the arrangement of the 
particles. It also enabled us to quantify the traffic of neutrophils between swarms formed 
around targets that are heterogeneous in size, a situation that closely resembles the transient 
swarms observed during in vivo infections.11 However, unlike typical infections, swarming 
around zymosan particles is likely triggered by the first neutrophils interacting with the 
target rather than soluble signals diffusing from the infection site. The first neutrophils arrive 
to the targets by chance during the loading of the devices and subsequent neutrophils are 
guided by mediators released from the first cells. In the presence of serum, an additional 
mediator for the early interactions between neutrophils and targets may be complement 
factors converted to chemoattractants in the presence of zymosan 20,21. This potential 
mechanisms is dispensable however, as demonstrated by our experiments in which swarming 
occurs in serum free media. The mechanism of swarm initiation in our experiments also 
appears to be independent of cell or tissue damage 1,2,22 and does not require the presence of 
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monocytes 6. The processes replicated on the microscale array of particle-clusters is thus 
relevant to neutrophil-pathogen encounters during infections.
One of the intriguing findings using the swarming array is that several mediators contribute 
to the robust swarming of human neutrophils. Among these, LTB4 plays the dominant role 
during human neutrophil swarming, similar to the findings in mice from single gene 
knockouts. In addition to LTB4, we found that other mediators can also contribute to 
swarming, e.g. CXCL8 and complement factors, but only when the actions of LTB4 are 
inhibited. The ability of neutrophils to produce CXCL8 is consistent with previously reports 
of LTB4 and CXCL8 production by neutrophils after interaction with zymosan 
particles 23,24, and the conversion of complement factors in plasma following incubation 
with zymosan 21. In addition to these factors, we also identified ten swarming-specific 
proteins released during the early stages of swarming. Four of these (Galectin-3, Nidogen-1, 
CXCL7, and TSP-1) are known to enhance human neutrophil motility25–28. Several others 
are known to contribute to the activation of monocytes (CXCL7) 29, lymphocytes (PGRP-
S) 30, and fibroblasts (PDGF-BB) 31, and endothelial cells (Galectin-3) 32. Lipocalin-2, an 
iron sequestering protein that limits bacterial growth 33, and Galectin-3, an antimicrobial 
protein with activity against bacteria and fungi 32, interfere with microbial activities in the 
tissues and are produced in significantly higher amounts during swarming compared to 
phagocytosis controls. All mediators that are significantly higher during swarming display a 
monotonic concentration increase after the start of the swarm. One notable exception is 
complement activator Pentraxin-3 34. It is possible that Pentraxin-3 is degraded by the 
proteases released during swarming as a mechanism limiting inflammation. The balance 
between proteases and inhibitors e.g tissue inhibitor of matrix metalloproteinase (TIMP-1), 
which is released in large amount during swarming, appears to be important for the 
interaction between swarms and the local tissue environment, enabling the accumulation of 
more neutrophils, while at the same time limiting the potential damage to tissues 35. 
Together, these signals coordinate not only the growth of neutrophil swarms, but the 
interactions with other immune and non-immune cells, to accomplish fast and robust 
responses that will protect healthy tissues from injuries and/or infectious aggressions.
In contrast to the large number of protein mediators that serve to enhance neutrophil 
accumulation during swarming, only two of the superfamily of resolution phase signals that 
stop neutrophil recruitment were identified during the development of the neutrophil 
swarms. These include lipoxin A4 (LXA4) and resolvin E3 (RvE3) 36, two very potent 
mediators of inflammation resolution 37. Their role in controlling swarm size is new, 
consistent with their production during the plateau phase of swarming, and with reduced size 
and slower growth of the swarms in the presence of LXA4. Although the recruitment role of 
PGD2 for some leukocytes has been reported 38, this is the first evidence that human 
neutrophils produce PGD2 during neutrophil swarming. Our findings are in agreement with 
experiments in which combinations of elevated levels of LTB4 and PGD2 are found in the 
airways, bronchoalveolar lavages (BALs), and exhaled breath condensates of asthma 
patients 39,40. The same signals may be at play in patients in critical condition 41 and provide 
an explanation for our observations of the reduced size of swarms in this patient population. 
The deficit in swarming may also be due to inability of the neutrophils from patients to 
follow chemical gradients, to release chemical mediators to stimulate other cells to migrate, 
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or both. Some of the motility defects for neutrophils from patients in critical condition are 
already known42, and more types of defects are likely to emerge from the detailed analysis 
of swarming using neutrophils from patients. Better understanding of the sources for 
swarming deficiencies will ultimately lead new treatments to enhance the ability of 
neutrophils to contain areas of tissue damage and infections and reduce the susceptibility for 
infections in patients during critical care 43.
Methods
Chemicals
Commercially available high molecular weight cationic copolymer of polyacrylamide and 
quaternized cationic monomer (ZETAG 8185, BASF, Florham Park, NJ, USA) was used as 
ink for PDMS microstamps. Fluorescent zymosan derived from S. cerevisiae was used as 
model, yeast-like target (Z2843, Life Technologies, Carlsbad, CA, USA). Zymosan particles 
were treated with an opsonizing reagent (Z2850, Life Technologies, Carlsbad, CA, USA) 
before use, following a protocol provided by the manufacturer. Glutaraldehyde, osmium 
tetraoxide, and 0.1 M sodium cacodylate were used for neutrophil fixation. U75302 and 
LY255283 (Catalog number: 70705 and 70715, Cayman Chemicals, Ann Arbor, MI, USA) 
were used as BLT1 and BLT2 receptor antagonists during LTB4 production. LXA4 (Catalog 
number: 90410, Cayman Chemicals, Ann Arbor, MI, USA) was used as an exogenous 
inhibitor for neutrophil migration. Human CXCR1 and CXCR2 antibodies (Catalog 
Number: MAB330 and MAB331, R&D Sytems, MN, USA) were used to block recognition 
of secreted IL-8 by activated neutrophils. We used heat-inactivated serum (System 
Biosciences, Mountain View, CA, USA) to test the influence of heat-labile C5a and C3a 
factors during neutrophil recruitment.
Microfabrication of the stamp
Device fabrication was performed using standard soft-lithography techniques on a four-inch 
wafer. Three layers of photoresist (SU-8, Michrochem, Newton, MA, USA) were spun onto 
a silicon wafer. The photoresist was exposed to UV light using a mask aligner (Neutronix 
Quintel), and the unexposed photoresist was developed away to yield multiple arrays of 
posts with heights of 15 µm, diameters of 10 or 20 µm, and spacing of 20, 40, 80, 100, or 
200 µm. A 10:1 ratio of polydimethylsiloxane (PDMS) and its curing agent (SYLGARD 184 
A/B, Dow Corning, Midland, MI, USA) was poured onto wafers and cured overnight at 
65 °C. The PDMS layer was peeled off and the arrays of posts were punched out using an 8 
mm biopsy punch (Harris Uni-Core, Ted Pella Inc, Redding, CA, USA) to create stamps.
To prepare the stamps for patterning, high molecular weight cationic FITC-ZETAG was used 
as ink. Stamps were placed face up, and 100 µL of ink was pipetted onto the PDMS micro 
post array. The stamps were then placed face down into a reservoir dish containing 1 mL of 
ink and allowed to incubate for at least 10 minutes. Stamps were then pressed onto a glass 
slide to remove excess ink, before being pressed with 3.7 g weights onto a plasma treated 
glass slide (Fisherbrand Double Frosted Microscope Slides, Fisher Scientific, Waltham, MA, 
USA). Stamps were spaced into wells using 8-well imaging spacers. After 5 minutes, 
weights and stamps were removed and allowed to dry to yield patterned ZETAG. For each 
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patterned slide, we cut 8 mm wells using a biopsy punch in flat, 2 mm thick pieces of 
PDMS. The wells were sealed to the glass using a double-stick spacer (Secure-Seal, Grace 
Bio-Labs, Bend, OR, USA).
Fluorescent zymosan particle clusters were used as targets for neutrophils swarms. A 
solution of 0.5 mg/mL zymosan particles in ultra-pure water was pipetted onto the patterned 
ink and was allowed to adhere to the ink by electrostatic interactions. Excess zymosan was 
then washed away by flushing thoroughly with deionized water, and samples were stored at 
4°C.
Neutrophil Isolation
Fresh human blood samples from healthy volunteers, aged 18 years and older, were 
purchased from Research Blood Components (Allston, MA, USA). All blood specimens 
from patients were obtained with informed consent according to an institutional review 
board (IRB) approved protocol at the Massachusetts General Hospital. Peripheral blood was 
drawn into heparinized-tubes (Vacutainer; Becton Dickinson, Woburn, MA, USA) and 
human neutrophils were isolated within 2 hours after blood collection using EasySep Human 
Neutrophil Enrichment Kits by following manufacturer instructions (STEMCELL 
Technologies, Vancouver, Canada). After isolation, neutrophils were washed using cell 
culture medium, and the nuclei were stained with Hoechst 33342 trihydrochloride dye (Life 
Technologies, Woburn, MA, USA). Stained neutrophils were then resuspended in medium at 
a density of 7.5 × 105 cells per mL. Two hundred microliters of cell suspension were then 
pipetted into each well containing the array of zymosan particle clusters and sealed with a 12 
mm diameter coverslip. The purity of the neutrophils was estimated by flow cytometry 
(using anti-CD66b fluorescent antibodies and Hoechst nuclear stain). Less than 0.1% of the 
isolated neutrophils had platelets attached to their surface (quantified using anti-CD61 
fluorescent antibodies - Supplementary Fig. 10.).
Neutrophil Inhibition
LY255283 was dissolved in ethanol. LY255283, U75302, and LXA4 solutions were vacuum 
dried for 5 min. Each compound was re-suspended in cell culture media at a concentration 
of 20 µM for LY255283 and U75302 and 5 µM for LXA4. For BLT1&2 inhibition, isolated 
neutrophils were re-suspended at 1/1 volume ratio of LY255283 and U75302 and incubated 
for 10 min before to add the neutrophils on the swarming assay. For testing the effect of 
LXA4 on neutrophil migration during swarming, neutrophils were re-suspended on 5 µM 
LXA4 and added to the assay immediately.
Neutrophil Imaging
After neutrophil loading, cell behavior was recorded using time-lapse imaging at 10x 
magnification in a fully automatic Nikon TiE microscope (Micro Device Instruments, Avon, 
MA, USA) with a heated incubator to 37°C and 5 % CO2. The maximum time resolution of 
acquisition was 0.2 frames per second to achieve accurate neutrophil tracking.
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Swarm Size Measurement
Swarm size and size changes over time were estimated using the surface segmentation 
module in Imaris. The cell-occupied area was measured from the Hoechst labeled 
neutrophils using a 2 pixel smoothing filter with background subtraction and automatic 
thresholding. Individual cells not contacting the particle cluster were excluded with a 
minimum area filter of 5 µm, and an automatic minimum intensity filter in the particle 
cluster (zymosan) TxRed channel. This allowed us to measure the area over time of the 
remaining single surface object, which corresponded to cells within the swarm contiguous 
with the particle cluster.
Single Neutrophil Tracking
Cells were tracked using Imaris spot detection and tracking (Bitplane). Cells were detected 
with a spot radius of 5 µm (to match the approximate cell size), with background subtraction 
enabled and with a minimum quality of 1.7. Tracking was performed using an autoregressive 
motion model, with a maximum displacement of 5 µm and a maximum gap length of 3 
frames. Tracks were eliminated which did not have a duration spanning at least ½ of the 
dataset. Cell tracks were then exported for analysis in Matlab.
Chemotaxis Analysis
The instantaneous chemotactic index (CI) at time t was then calculated as: 
where:  is the rate of change of the distance between the cell’s position x 
and the zymosan particle cluster position z. Prior to chemotaxis, analysis the cell track 
positions x were smoothed by spline fitting (MATLAB function spaps), with a tolerance 
selected for each track such that 95% of the spline fit residuals were ≤ 2.5 µm, the 
approximate average cellular radius. Clusters of zymosan particles were segmented by Otsu 
thresholding followed by selection of the largest connected component, and z was set to be 
the centroid of this object. Cellular migration speed (spline smoothed) is calculated as: 
.
Chemotactic index maps were created by averaging the CI of all cells within the specified 
distance and time bins. The maximum distance for these maps was set based on the 
minimum distance from the particle cluster centroid z to the image border, and thus the 
radius of the largest circle centered on the particle cluster that was completely contained 
within the image. Because the distance to the particle cluster is approximated by its centroid, 
the true distance will differ depending on the shape and radius of this particle cluster. To 
minimize the effect of this error, the minimum distance for the CI maps was set to: 
 where a is the area of the zymosan particle cluster. This distance cutoff 
corresponds to the radius where the distance error would exceed 50% for a disk shaped 
particle cluster with the same area.
Reátegui et al. Page 11
Nat Biomed Eng. Author manuscript; available in PMC 2017 December 30.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Diffusion Modeling
Chemoattractant diffusion properties (including diffusion coefficients D) were estimated by 
simultaneously fitting both a diffusion model and a cellular response model to the measured 
chemotactic index maps. We modeled the concentration ci produced by a single 
instantaneous release of chemoattractant at time ti as:
where r is the distance from the particle cluster, t is time, mi is the mass of chemoattractant 
released, and D is the diffusion coefficient. The factor of 2 accounts for the fact that the 
domain into which the chemoattractant is being released is bounded on one side by the 
coverslip to which the cells and particle cluster are adhered (using the principle of 
superposition). Releases of finite duration were modeled by the superposition of these 
instantaneous releases. For example, the concentration C(r, t) resulting from a continuous 
release starting at time Tr was modeled as:
with the vector t of individual release times ti set to
where Te is the end of the image series and where Δ was set to 1 second (1/5th of the 
imaging interval). This diffusion model was then linked to cellular chemotaxis via a cellular 
response model:
where CIp(r, t) is the predicted mean chemotactic index at a given radius and time, with pb 
the basal chemotactic index (in the absence of chemoattractant), pm is the maximum CI, s is 
the slope of the cellular response to chemoattractant and C0 is the concentration at which the 
cellular CI response is half of its maximum (.5pm). All model free parameters were then 
estimated by least squares minimization:
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As this objective function is non-convex, we used parallelized multi-start nonlinear least 
squares minimization (MATLAB MultiStart). We performed a parameter sweep of the 
number of starting points on a subset of the data to confirm that above 2000 initializations 
the resulting model fits and parameter estimates were stable.
Electron Microscopy
Neutrophil swarms were chemically fixed with 2 % glutaraldehyde in 0.1 M sodium 
cacodylate for 2 h. Then, samples were gradually dehydrated in different percentages of 
ethanol (50 %, 70 %, 80 %, 95 %, and 100 % V/V) for 15 min each. Samples were 
transferred to a CO2 critical point drier Autosamdri 931 (Tousimins, Rockville, MD, USA). 
Dried samples were sputtered with a Platinum/Palladium target at a rate of 10 Å/min for a 
total thickness of 10 nm. Scanning electron microscopy (SEM) was conducted with a Supra 
FV500 (Zeiss, Peabody, MA, USA). Samples were imaged at different magnifications using 
an accelerating voltage of 3 kV.
Lipid Mediator Metabololipidomics of Swarm Supernatant
Four different healthy donors were tested to compare temporal lipid mediator profiles. To 
minimize artifacts of neutrophil activation cells were isolated and not stained. After 
neutrophil isolation, cells were suspended in IMDM media without phenol red and 
supplemented with 0.4 % human serum albumin (HSA, Sigma-Aldrich, Saint Louis, MO, 
USA). The supernatant of different wells was collected at different time points (0, 0.5, 1, and 
3 h), flash frozen at −80°C, and stored. Supernatants were placed in 2 volumes of ice-cold 
methanol and kept at −20°C to allow for protein precipitation, and lipid mediators were 
extracted using solid-phase extraction as in 44. Briefly, before sample extraction, deuterated 
internal standards (d4-PGE2, d5-LXA4, d4-RvD2, d4-LTB4, d5-LTC4 and d8-5S-HETE) 
representing regions of interest in the chromatographic analysis (500 pg each) were added to 
facilitate quantification. Extracted samples were analyzed by an LC-MS-MS system, Qtrap 
6500 (AB Sciex) equipped with a Shimadzu SIL-20AC autoinjector and LC-20AD binary 
pump (Shimadzu Corp.). An Agilent Eclipse Plus C18 column (100×4.6mm×1.8µm) was 
used with a gradient of methanol/water/acetic acid of 55:45:0.01 (vol:vol:vol) that was 
ramped to 85:15:0.01 (vol:vol:vol) over 10 min and then to 98:2:0.01 (vol:vol:vol) for the 
next 8 min. This was subsequently maintained at 98:2:0.01 (vol:vol:vol) for 2 min. The flow 
rate was maintained at 0.4ml/min. To monitor and quantify the levels of lipid mediators, a 
multiple reaction monitoring (MRM) method was developed with signature ion fragments 
(m/z) for each molecule monitoring the parent ion (Q1) and a characteristic daughter ion 
(Q3). Identification was conducted using published criteria for each molecule where a 
minimum of 6 diagnostic ions were employed 44. Calibration curves were determined using 
a mixture of synthetic lipid mediators standards obtained via total organic synthesis. Linear 
calibration curve for each compound was obtained with r2 values ranging from 0.98 to 0.99. 
The detection limit was ∼0.1 pg for each lipid mediator. Quantification was carried out as 
detailed in ref. 44.
Released Proteins Analysis
The analysis for the presence of cytokines and chemokines released during swarming was 
conducted at RayBiotech (Norcross, GA, USA) using a high throughput sandwich ELISA-
Reátegui et al. Page 13
Nat Biomed Eng. Author manuscript; available in PMC 2017 December 30.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
based quantitative array platform Q9000. We tested neutrophil swarming supernatants 
against over 400 proteins. Each protein was tested in quadruplicate. For protein 
quantification, the array had each single protein as a control and at known concentrations to 
generate standard curves for each protein. By comparing signals from the samples to the 
individual standard curves, the protein concentrations in the samples were determined.
Statistical Analysis
Differences in secreted proteins levels between swarms and resting neutrophils were 
evaluated using the software package JMP (Version 11). The Shapiro-Wilk test was used to 
ensure the data were normally distributed, and homogeneity of variance was tested using 
Levene’s test. ANOVA Randomized Complete Block Design (RCB) was then performed as 
appropriate. Where statistically significant differences were found in the ANOVA, the 
Tukey-Kramer HSD test was carried out to find out which groups differed. When the 
assumptions (normality and homoscedasticity) were not valid, ANOVA on the transformed 
data or Kruskal-Wallis test was conducted. Differences were deemed statistically significant 
for p values of less than 0.05.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Human neutrophil swarming on large scale zymosan particle arrays
(a) Scanning electron micrograph (SEM) image of zymosan particle clusters patterned by 
electrostatic physisorption on 10 µm stamped ZETAG spots (scale bar: 20 µm). (b) SEM 
images of neutrophils in blue and zymosan particles in red at different stages of swarming. 
Early neutrophil scouting (left), neutrophil recruitment (center), neutrophil swarm 
completely covering zymosan particle clusters (right, images are at different magnifications, 
scale bar 5 µm for all panels). (c) An array of neutrophil swarms generated in the 
microfluidic assay at 60 min. Particle cluster targets are covered by neutrophils (blue), while 
other neutrophils are activated and migrating towards the swarms (scale bar: 20 µm). (d) 
Swarming depends on size of particle cluster and spacing between clusters. Particle cluster 
area represents the projection of each aggregate of zymosan particles. Cluster spacing is 
defined as the distance between adjacent clusters. Swarms form on particle clusters that have 
an area larger than 17 µm2 and are spaced further than 20 µm. Swarms have sizes 
significantly larger than the particle cluster area. Representative experiment of N = 10. (e) 
Swarming size and dynamics are reproducible. Neutrophil samples from the same donor 
display similar swarming dynamics on clusters of comparable area in three separate 
experiments (N = 3, technical replicates). (f) Neutrophils from different healthy donors form 
swarms that display distinct temporal dynamics and reach distinct sizes. The variability 
between donors is larger than the differences measured in samples from the same donor. 
Each donor has been measured in three separate experiments (N = 3). Error bars represent 
standard deviations for these measurements. (g) Neutrophils (blue) traffic from the smaller 
to the larger zymosan cluster (red), contributing to the growth of larger swarms around the 
larger targets. The trajectories of the neutrophils joining the larger swarm to the left, on top 
of a large particle cluster are represented as solid white lines, while those leaving the smaller 
swarm to the right, formed on top of a small particle cluster are represented as dashed 
yellow tracks. (Scale bar: 15 µm). (h) When zymosan clusters of different size are closer 
than ∼60 µm, neutrophils traffic from the smaller to the larger target, producing larger 
swarms around the larger targets. The relative size of the swarms for various distances 
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between targets is indicated in the pie charts, the absolute size is presented in numbers next 
to the charts. The larger clusters (A1) have areas between 50 and 60 µm2 while the smaller 
clusters (A2) have areas between 35 and 45 µm2. (N = 10 experiments, N = 100 adjacent 
swarms).
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Figure 2. The migration of neutrophils towards swarms is altered in the presence of BLT1 and 
BLT2 antagonists
a–d. Characterization of neutrophil swarming in control experiments. (a) Neutrophils (blue) 
from healthy donors form large swarms around zymosan particle clusters (red) at 60 min 
(scale bar 100 µm). (b) Moving neutrophils display radial trajectories, centered on the 
particle cluster (scale bar 100 µm). (c) The speed of migration increases significantly at the 
end of the scouting phase and remains high during the accelerated growth phase of 
swarming (density plot of instantaneous migration speed for individual neutrophils). (d) The 
chemotactic index towards the particle clusters remains high over time, in agreement with 
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the qualitative aspects of the migration tracks (density plot of the instantaneous chemotactic 
index for individual neutrophils). A histogram of the distribution of chemotaxis indexes for 
the duration of the experiment. Panels a-d show representative experiments of N = 16. e–h. 
Characterization of neutrophil swarming in the presence of BLT1 and BLT2 receptors 
antagonists. (e) Neutrophils from the same healthy donors form smaller swarms in the 
presence of BLT1 and BLT2 receptors antagonists (60 min, scale bar: 100 µm). (f) 
Neutrophil migration patterns are more convoluted in the presence of BLT1 and BLT2 
receptors antagonists (scale bar:100 µm). (g) The speed of migration is reduced and stable 
over time in the presence of BLT1 and BLT2 receptors antagonists. (h) The directionality of 
migration decreases and migrations away from the particle clusters become apparent (bi-
directional migration pattern) in the presence of BLT1 and BLT2 receptors antagonists. A 
histogram of the distribution of chemotaxis indexes for the duration of the experiment shows 
a more shallow distribution compared to the controls. Panels e-h show representative 
experiments of N = 14. (i) Neutrophils are recruited from an area around the particle 
clusters, which has a radius that is ∼50% shorter in the presence of receptor antagonists 
compared to controls (N = 16). The recruitment radius was measured as the maximum 
distance at which at least one neutrophil was recruited towards the target. We only 
considered the neutrophils that migrated persistently along the radial direction, towards the 
zymosan targets. Each dot represents a separate experiment for which at least 100 
neutrophils were tracked towards the zymosan targets. (j) The ratio between the area of the 
swarm and the area of the particle cluster decreases in the presence of BLT1 and BLT2 
antagonists compared to controls (N = 14). Red bars, mean (i–j). k–n. Biophysical model 
results and comparison to experimental data are consistent with the switch from a low 
molecular weight to a high molecular weight chemoattractant directing the neutrophils 
towards the swarm. (k) and (m) represent the experimental results for the control and 
antagonist conditions, showing that neutrophils are recruited from progressively larger areas 
around the particle clusters. (l) and (n) show the simulation results for fast and slow 
diffusing chemoattractants (1.2 and 0.6 × 10−10 m2/s, respectively), produced at the location 
of the swarm, and released at comparable rates. The different colors on the graphs represent 
the chemotactic index, coded as detailed in the color bars to the right. On the color coded 
bar, 1 represents accurate radial migration towards the swarm, and −1 radial migration away 
from the swarm. The model provides support for the presence of at least one additional 
chemoattractant besides LTB4 directing the migration of neutrophils towards swarms. Panels 
k-m show representative experiments of N = 5.
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Figure 3. Evaluation of soluble factors guiding neutrophil migration during swarming
(a) In control conditions, swarms of neutrophils (blue) around patterned zymosan particle 
clusters (red) are observed at 5, 30 and 60 minutes. The contour of the swarms is 
emphasized by dashed white lines (scale bar: 20 µm; Representative experiment of N = 5). 
(b) Swarms grow slower and reach a smaller size in the presence of BLT1, BLT2, CXCR1 
and CXCR2 receptor antagonists. (scale bar: 20 µm; Representative experiment of N = 5) (c) 
Changes in the chemotactic index (CI) during neutrophil swarming at various conditions of 
soluble factor inhibition. Control vs. Heat-inactivated serum (HI, p < 0.05), HI vs. CXCR1 
and CXCR2 antagonists (p >0.05), CXCR1 and CXCR2 antagonists vs. BLT1 and BLT2 
antagonists (p < 0.05), BLT1 and BLT2 antagonists vs. CXCR1, CXCR2, BLT1 and BLT2 
antagonists (p < 0.05). Error bars represent minimum and maximum value of the 
experimental group (*p < 0.05). (d) Comparison of the effect of heat-inactivated serum and 
BLT1 and BLT2 antagonists on the recruitment of neutrophils during swarming. (e) 
Inhibition of BLT1 and BLT2 and CXCR1 and CXCR2 for LTB4 and CXCL8 
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chemoattractants showed slower growth of swarms. Figures d–e show representative 
experiments of N = 5.
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Figure 4. Lipid mediators released by human neutrophils during swarming
(a) Inflammation-initiating and pro-resolving lipid mediators released during human 
neutrophil swarming. Reference MS-MS fragmentation spectra employed for identification 
of PD1 and LXA4 (N = 4 donors, n = 1850 swarms). (b) Transient profiles of inflammation 
mediators LTB4, PGD2, and PGE2, and resolution mediators LXA4, RvE3, and PD1, 
released during neutrophil swarming show different temporal dynamics. c) Characterization 
of neutrophil migration in the presence of exogenous LXA4. [5 µM]. The recruitment 
profiles over time are slower in the presence of LXA4 compared to the control sample and 
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result in swarms with lower ratio of swarm to target size (δRatio). Error bars represent 
standard error of the mean (* p < 0.05, N = 3 experiments).
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Figure 5. Cytokines released by human neutrophils during swarming
(a) Swarming-specific cytokines released at one hour after the start of swarming have 
different levels levels during swarming compared to non-swarming and non-activated 
controls (N = 4 donors, N = 2540 swarms, p < 0.05). Please note the logarithmic scale along 
the concentration axis. (b) Quantitative protein microarrays helped identify cytokines 
released by neutrophils at one hour after the initiation of swarming on zymosan particle 
clusters. Cytokines that are present in the supernatant at significantly different levels 
between swarms, non-swarms, and non-activated controls (N = 4 donors, N = 2540 swarms, 
p < 0.05). (c) Three distinct temporal profiles for swarming-specific cytokines were 
identified by comparing supernatants collected at 0, 30, 60 and 180 minutes. Several 
cytokines increased in concentration over time (e.g. Adipsin, Galectin 3, Nidogen-1, TLR2, 
Cathepsin-S), some reached a plateau after 90 minutes (e.g. CXCL7, PDGF0BB, TIMP-1, 
TSP-1), and one decreased over time (Pentraxin-3). Error bars represent standard error of the 
mean.
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Figure 6. Analysis of clinical samples during neutrophil swarming
(a) Time-lapse fluorescence microscopy images of neutrophils swarming for healthy 
individuals and patients. Neutrophils from healthy individuals develop stable swarms after 1 
h of persistent migration. Neutrophils from patients do migrate persistently towards the 
zymosan particle targets (green arrows). (b) The size of neutrophil swarms is decreased in 
patients after major trauma, autoimmune diseases, and sepsis. Error bars represent the 
minimum and maximum value of the experimental group. (N = 4, * p < 0.05, Student’s t-
test). (c) The size of neutrophil swarms is decreased early in trauma patients compared to 
controls and recovers over time. Error bars represent the minimum and maximum value of 
the experimental group (N = 7; * p < 0.05, Student’s t-test). (d) Comparison of neutrophil 
recruitment over time shows that the neutrophils from patients (black) accumulate to swarms 
slower and the swarms grow at slower rate and reach smaller size compared to healthy 
controls (red) (N = 2 experiments, N=20 swarms, error bars represent standard error of the 
mean).
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